H2AX and cancer: With that, H2A.X-deficient cells are more sensitive to DNA damaging agents and such H2A.X mutations are being observed in a number of cancers, such as sarcomas, brain tumor, neck squamous cell carcinoma and are predominantly prone to B and T cell lymphomas [47,48].